Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value
$239.52M
Total Bought
$107.01M
Total Sold
$77.21M
Net Transaction
+$29.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
NEKTAR THERAPEUTICS COM NEW(NKTR)0300,000+300,000017,0707.13%+17,070
SOLENO THERAPEUTICS INC0225,000+225,000015,2106.35%+15,210
ASCENDIS PHARMA A/S SPONSORED ADR(ASND)075,000+75,000014,9116.23%+14,911
ZURA BIO LTD CLASS A ORD SHS(ZURA)3,170,1943,815,930+645,7363,32916,5236.90%+13,194
APOGEE THERAPEUTICS INC(APGE)0304,000+304,000012,0785.04%+12,078
DIANTHUS THERAPEUTICS INC(DNTH)0265,803+265,803010,4594.37%+10,459
AMYLYX PHARMACEUTICALS INC(AMLX)2,000,0001,700,000-300,00012,82023,1039.65%+10,283
REZOLUTE INC COM NEW(RZLT)3,033,4622,451,809-581,65313,52923,0479.62%+9,518
EUPRAXIA PHARMACEUTICALS INC(EPRX)01,200,000+1,200,00007,0802.96%+7,080
PHARVARIS N V
COM
0155,105+155,10503,8701.62%+3,870
IMMUNOVANT INC(IMVT)262,176500,000+237,8244,1958,0603.37%+3,865
ORUKA THERAPEUTICS INC(ORKA)0183,330+183,33003,5251.47%+3,525
CYTOKINETICS INC COM NEW(CYTK)150,000150,00004,9568,2443.44%+3,288
ABIVAX SA SPONSORED ADS(ABVX)1,291,617150,000-1,141,6179,88112,7355.32%+2,854
SANA BIOTECHNOLOGY INC(SANA)0700,000+700,00002,4851.04%+2,485
ABSCI CORPORATION0796,438+796,43802,4211.01%+2,421
UPSTREAM BIO INC(UPB)300,000300,00003,2945,6432.36%+2,349
XENON PHARMACEUTICALS INC(XENE)200,000200,00006,2608,0303.35%+1,770
CONTEXT THERAPEUTICS INC(CNTX)4,683,7114,683,71103,0694,5381.89%+1,469
TAYSHA GENE THERAPIES INC COM SHS(TSHA)1,500,0001,500,00003,4654,9052.05%+1,440
JADE BIOSCIENCES INC COM NEW498,054632,599+134,5454,9765,4592.28%+484
NEUROGENE INC(NGNE)485,859446,814-39,0457,2647,7433.23%+480
DBV TECHNOLOGIES S A SPONSORED ADS(DBVT)374,679378,594+3,9153,4323,7861.58%+354
PLIANT THERAPEUTICS INC(PLRX)850,000850,00009861,2580.53%+272
HELIX ACQUISITION CORP II29,3810-29,3813120—-312
UNICYCIVE THERAPEUTICS INC COM NEW(UNCY)796,558796,55803,8003,4731.45%-327
AKERO THERAPEUTICS INC103,848103,84805,5414,9312.06%-611
PROMIS NEUROSCIENCES INC2,645,1280-2,645,1281,2800—-1,280
SCHOLAR ROCK HLDG CORP(SRRK)61,6070-61,6072,1820—-2,182
CENTESSA PHARMACEUTICALS PLC225,0000-225,0002,9570—-2,956
KALVISTA PHARMACEUTICALS INC323,1700-323,1703,6530—-3,653
ARCELLX INC
COMMON STOCK
100,0000-100,0006,5850—-6,585
EVOLUS INC(EOLS)720,1180-720,1186,6320—-6,632
AKEBIA THERAPEUTICS INC(AKBA)1,985,9150-1,985,9157,2290—-7,229
LEGEND BIOTECH CORP SPONSORED ADS(LEGN)350,000113,460-236,54012,4223,7001.54%-8,722
IONIS PHARMACEUTICALS INC(IONS)500,00080,000-420,00019,7555,2342.19%-14,521
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q3 2025 | TickerTrail